Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CF2105 is a skincare product currently in the product development stage, developed by Zhongke CELFULL Mitochondrial Medicine. It is specifically designed for anti-wrinkle applications, leveraging the company's focus on mitochondrial medicine to address signs of skin aging. While the specific active ingredients and molecular targets have not been publicly disclosed, the product is part of a broader pipeline that applies mitochondrial science to therapeutic, nutraceutical, and cosmetic health. As a skincare candidate, it is intended for topical application to improve skin texture and reduce the appearance of wrinkles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CF2105.